Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:942196.
doi: 10.1155/2014/942196. Epub 2014 Jun 9.

Electroacupuncture improves trinitrobenzene sulfonic Acid-induced colitis, evaluated by transcriptomic study

Affiliations

Electroacupuncture improves trinitrobenzene sulfonic Acid-induced colitis, evaluated by transcriptomic study

Tin-Yun Ho et al. Evid Based Complement Alternat Med. 2014.

Abstract

Inflammatory bowel disease is a chronic colonic inflammation that displays symptoms like diarrhea and weight loss. Acupuncture has been widely accepted by Western countries for the treatment of pain. Here, we analyzed efficacy and mechanism of electroacupuncture (EA) on trinitrobenzene sulfonic acid- (TNBS-) induced colitis in mice. Mice were intrarectally administered with 250 mg/kg TNBS and electroacupunctured at Quze (PC3) and Neiguan (PC6) acupoints, which have been applied for gastrointestinal disorders. Gene expression profiles in colons and spleens were analyzed by microarray for the elucidation of mechanism of EA. Our data showed that EA at PC3 and PC6 improved macroscopic and microscopic features of colitis and the improvement displayed a frequency-dependent manner. Administration of TNBS upregulated the expression of most cytokine genes in colons, while EA downregulated the expression of TNBS-induced cytokine genes. Pathway analysis showed that EA significantly affected inflammatory pathways in colons and immunity-associated pathway in spleens. Immunohistochemical staining further showed that EA decreased the expression of interleukin-1 β and nuclear factor- κ B. In conclusion, this is the first study reporting the global gene expression profiles of EA on TNBS-induced colitis. Our findings suggested that inflammatory and immunity pathways were involved in the anti-inflammatory mechanism of EA on colitis induced by TNBS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Experimental protocol. (a) Location of PC3 and PC6 acupoints. (b) Experimental design. Mice were given TNBS once and then electroacupunctured at PC3 and PC6 acupoints for 20 min once a day. EA was performed for consecutive 7 days. Mice were sacrificed 7 days after TNBS administration.
Figure 2
Figure 2
Effect of EA on TNBS-induced colitis in mice. Mice were intrarectally administered with 250 mg/kg TNBS once and/or various frequencies of EA for 20 min daily. Seven days later, mice were sacrificed and examined for colitis by macroscopic lesion and microscopic sections. (a) Macroscopic and microscopic features of colons. Photos are representative images (n = 8/group). (b) Quantification of colitis severity. Values are mean ± standard error (n = 8/group). *P < 0.05, **P < 0.01, and ***P < 0.001, compared with mock. # P < 0.05, ## P < 0.01, compared with TNBS.
Figure 3
Figure 3
Effect of EA on the NF-κB and IL-1β expression in colons by IHC. Mice were administered with TNBS once and/or 100 Hz EA for 20 min daily. Seven days later, mice were sacrificed and colons were stained with antibodies against NF-κB and IL-1β (400x magnification). Photos are representative images (n = 8/group).
Figure 4
Figure 4
Schematic diagram illustrates the anti-inflammatory mechanism of EA at PC3 and PC6 in TNBS-induced colitis.

Similar articles

Cited by

References

    1. Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. Journal of Digestive Diseases. 2010;11(3):134–147. - PubMed
    1. Friedman S, Blumberg RS. Inflammatory bowel disease. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 18th edition. New York, NY, USA: McGraw-Hill; 2012.
    1. Engel MA, Neurath MF. New pathophysiological insights and modern treatment of IBD. Journal of Gastroenterology. 2010;45(6):571–583. - PubMed
    1. Ben-Horin S, Kopylov U, Chowers Y. Optimizing anti-TNF treatments in inflammatory bowel disease. Autoimmunity Reviews. 2014;13(1):24–30. - PubMed
    1. Antoni C, Braun J. Side effects of anti-TNF therapy: current knowledge. Clinical and Experimental Rheumatology. 2002;20(6, supplement 28):S152–S157. - PubMed